Preventive Effect of Heparin Combined with Low Molecular Heparin on Primary Thrombosis in Arteriove-nous Fistula Patients
- VernacularTitle:肝素联合低分子肝素预防动静脉内瘘术后早期血栓形成
- Author:
Xing FAN
;
Li LIN
;
Xingfeng REN
;
Jun PENG
;
Tianbiao LAN
- Publication Type:Journal Article
- Keywords:
Heparin;
Low molecular heparin;
Chronic renal failure;
Arteriovenous fistula;
Thrombosis
- From:
China Pharmacist
2015;(8):1328-1330
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the efficacy of heparin combined with low molecular heparin against early thrombosis in chronic patients after native arteriovenous fistula ( AVF) . Methods: A total of 299 patients were enrolled in the study from January 2012 to December 2014 and randomly divided into two groups. The control group received 5000IU low molecular heparin after the operation for 7 days and the trial group received 3 000u heparin additionally through free arterial end and venous terminal during the operation. The thrombosis formation rate and adverse drug reactions ( ADR ) of one week and 4 weeks after the operation were observed in the two groups. Results:One week after the operation, the thrombosis formation rate in the control group and the trial group was 3. 4% and 0, respectively, and four week after the operation, that was 4. 8% and 0. 67%, respectively. The incidence of ADR showed no statistical-ly difference between the two groups (P>0. 05), and no severe ADR appeared in both groups. Conclusion:Heparin combined with low molecular heparin may be more effective and safer in the prevention of primary thrombosis in the patients after AVF.
